ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eric Manasse
Hisayoshi Suma
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manasse, E.
Right arrow Articles by Possati, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manasse, E.
Right arrow Articles by Possati, G. F.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:1076-1082
© 1996 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Use of the Radial Artery for Myocardial Revascularization

Eric Manasse, MD, Giovanni Sperti, MD, Hisayoshi Suma, MD, Carlo Canosa, MD, Amir Kol, MD, Lorenzo Martinelli, MD, Rocco Schiavello, MD, Filippo Crea, MD, Attilio Maseri, MD, Gian Federico Possati, MD

Cardiac Surgery Department, Institute of Cardiology, and Cardioanesthesia Department, Università Cattolica del Sacro Cuore, Rome, Italy


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Background. The radial artery was first used as a coronary graft by Carpentier and associates in 1973 but, due to the disappointing results, it was abandoned. In 1992 its revival coincided with the widespread use of calcium-channel blockers in cardiovascular surgery, in the belief they could prevent spasm.

Methods. From January 1993 to October 1995 we operated on 109 patients for myocardial revascularization employing the radial artery with two different surgical techniques: in 95 patients (group 1) it was "pretreated" by opening its fascia after a gentle hydrostatic dilation and then anastomosed to the aorta; in 14 patients (group 2) it was branched to another conduit. We had two operative deaths (1.82%).

Results. At a mean interval of 532.42 days 105 patients are still alive, 2 (1.86%) having died of abdominal tumors. Fifty-six patients (52.33%) underwent angiography at a mean interval of 334.42 days: the patency of the radial artery was 88.88% in group 1 and 62.50% in group 2. Indications and contraindications are discussed.

Conclusions. The radial artery is an easily manageable conduit whose early patency is very promising, although a longer follow-up is mandatory.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
See also page 1082.

The radial artery (RA) is a muscular artery lying under the antebrachial fascia between the brachioradialis muscle and the flexor carpi radialis. Its use as a graft for coronary revascularization was first proposed by Carpentier and associates [1] in 1973 but soon abandoned because of its strong tendency to spasm. Apparently this pitfall has recently been overcome by Acar and colleagues [2], who reported in 1992 improved early results due to the adjunct of calcium-channel blockers in the postoperative period. Since then a few groups have reported their experience with this conduit [35], the follow-up always taking place within 1 year and often exclusively noninvasive. In January 1993 we started a prospective study assessing the use of the RA in coronary artery bypass grafting (CABG). We operated on 109 patients during a period of 33 months. The aim of the study was to evaluate angiographically the short-term patency of the RA and to describe its wall properties [6]. Angiography was performed in more than 50% of the patients at a mean follow-up of 1 year, and the vasoconstrictor profile of the RA was defined.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
From January 1993 to October 1995, 109 patients received the RA as a graft for CABG, representing 10% of the total population who underwent isolated CABG at our institution during the same period. The patients consisted of 92 men (84.4%) and 17 women (15.6%) with a mean age of 58 ± 8.8 years (range, 30 to 75 years). Preoperative data on clinical history and coronary disease are shown in Table 1Go.


View this table:
[in this window]
[in a new window]
 
Table 1. . Preoperative Data
 
Patient Selection
Written, informed consent was obtained from each patient before the operation. At the beginning of our experience mean indications for the use of the RA were as follows: lack of suitable saphenous vein grafts (SVGs) and contraindications to the use of either the internal mammary artery (IMA) or the right gastroepiploic artery (GEA). Subsequently, after the first encouraging results, age and complete arterial revascularization became more relevant in the decision-making process. None of the patients underwent operation on an emergency basis. The following were considered general contraindications to the use of the RA: depressed ventilatory function as suggested by preoperative pulmonary function tests, chronic renal failure as suggested by a serum creatinine level greater than 2 g/100 mL, and a systolic blood pressure less than 100 mm Hg, as such conditions could prevent adequate calcium-channel blockers therapy in the immediate postoperative period, thus jeopardizing the patency of the graft in its most critical period. Absolute contraindications were previous trauma of either arm, the presence of an arteriovenous fistula in case of hemodialisis, rare anatomic vascular anomalies of the upper limb [7], or poor compensation of the ulnar artery as shown by dynamic Doppler evaluation. Each patient was submitted to a careful angiographic examination of the forearm vascular anatomy and supply before being considered eligible for CABG with the RA. Both a clinical examination and an instrumental evaluation of the nondominant arm supply, following a protocol previously reported by our group [8], were considered mandatory. Indeed, despite a previous negative Allen test, 6.2% of the patients proposed for RA harvesting were rejected after a positive dynamic Doppler test revealed inadequate compensation or the presence of either atherosclerosis or anatomic lesions of the upper limb arteries. All patients with a positive Allen test were discarded and no Doppler study was performed. Of the 188 patients, among whom 109 were finally operated on using the RA, who underwent a Doppler study, 3 (1.6%) showed an important blood flow velocity decrease in all the examined arteries of the upper limb, suggestive of atherosclerotic stenosis of the subclavian artery.

Radial Artery Harvesting and Preparation
The RA was taken down contemporaneously to any other surgical procedure, such as opening and cannulation of the patient or harvesting of any other conduit but the right IMA (RIMA). The nondominant arm was positioned horizontal and perpendicular to the patient's body. The incision was then made longitudinally from the wrist, somewhat proximally just lateral to the tendon of the flexor carpi radialis, toward the elbow, following the medial border of the brachioradialis muscle. The RA was then followed in its course, opening the thin fascia bridging between the brachioradialis muscle on one side and the flexor carpi radialis and pronator teres on the opposite. It is advisable to end the cutaneous incision a few centimeters before the cubital fossa to avoid any postoperative limitation of the elbow. An incision into the pedicle's fascia was made distally and gradually extended to the elbow to expose and free the RA. Major collateral branches were clipped (Pilling Division, Fort Delaware, WA) and divided. After the patient had been fully heparinized the proximal and distal vascular stumps were divided and the forearm was closed. The mean length and caliber of the RA were 21 cm and 1.6 mm, respectively. From this point the technique was different according whether a pretreated conduit (group 1) or a composite [9] one (group 2) was to be used. In the second case, the proximal anastomosis to the main conduit (IMA) was performed before the extracorporeal circulation was started. If a pretreated conduit was chosen the proximal end was cannulated, heparinized blood [10] was added to the saline solution, and papaverine was then gently injected at a pressure of less than 80 mm Hg [11]. Additional bleeding points were located and clipped at this time. With the RA maintained dilated, the subsequent opening of the pedicle's fascia and outer adventitial lining was performed easily. The RA was used in either direction, the only criterion being to obtain the best RA–coronary caliber match. All pretreated grafts were anastomosed to the aorta except one, which was branched to an SVG because of too generous proximal trimming. The composite grafts were not previously injected and were always anastomosed to the left IMA (LIMA).

Surgical Technique
The operations were performed at the Catholic University of Rome by different surgeons over a period of 34 months, with only minor operative changes depending on the surgeon. With regard to the myocardial protection technique, there was an important change in our policy in November 1993, when warm blood cardioplegia, anterograde/retrograde, at normothermia (37°C) took over from cold crystalloid cardioplegia in hypothermia (28°C). The first series of operations on 33 patients (30.27%) were performed with cold crystalloid cardioplegia, whereas the second series of 73 patients (66.97%) used warm blood cardioplegia. In 2 patients (1.83%) with relatively high serum creatinine levels and a favorable coronary anatomy the intervention was performed without extracorporeal circulation. In 1 patient (0.91%) aortic clamping was avoided because of a "porcelain" aorta and the intervention was carried out with a fibrillating heart. One patient (0.91%) required an associated surgical procedure at the time of operation because of an accessory atrioventricular pathway in a Wolff-Parkinson-White syndrome. A total of 335 distal anastomoses (DAs) were performed, with 3.07 ± 0.8 anastomoses per patient (range, 1 to 5). The mean aortic clamping time was 58.27 ± 19.7 minutes (range, 24 to 112 minutes). In 13 patients (11.9%) we used the composite technique (group 2), in 95 patients (group 1) (87.1%) the pretreatment technique was preferred, and in 1 patient (0.9%) a "mixed technique" had to be adopted because of too generous trimming of the RA's proximal stump. A total of 110 RA conduits were used in 109 patients: 1 RA was divided into two different grafts in 1 patient. Bilateral RAs were never used. The right RA was used only in 2 left-handed patients (1.83%). A total of 110 proximal RA anastomoses were performed: to the aorta in 93 grafts placed in 92 patients (84.54%), to the LIMA (1 free and 12 in situ) in 13 patients (11.81%), to the innominate artery in 3 patients (2.72%), and to an SVG in 1 patient (0.90%). With the RA a total of 121 DAs were performed (1.1 per patient). In 11 patients (10.09%) the RA was used as a sequential graft. In 18 patients (16.51%) it was anastomosed to an infarcted area. Complete revascularization was achieved in 90 patients (82.56%), whereas complete arterial revascularization was possible in only 48 patients (44.03%). The territorial distribution of the DAs is reported in Table 2Go.


View this table:
[in this window]
[in a new window]
 
Table 2. . Distal Anastomoses (Distribution and Grafts)
 
Pharmacologic Regimen
After the distal and proximal anastomoses were completed and while weaning from extracorporeal circulation was taking place, a 1 µg•kg-1•min-1 diltiazem (Tanabe, Osaka, Japan) infusion was started. The intravenous infusion of calcium-channel blockers was continued in the intensive care unit at the prescribed dose as long as the patient's hemodynamic status allowed it. Within 48 to 72 hours oral therapy was administered at increasing doses from 60 to 240 mg/day during the first week. The maintenance dose was then 120 mg/day administered twice a day (in the slow-release form) in addition to a routine antiplatelet regimen.

Follow-up
Most of the patients have been followed up at regular intervals (1 month, 3 months, and then every 6 months) in our institution. In addition to a clinical examination, a routine electrocardiogram, and a chest roentgenogram, the following examinations were performed only when indicated: 24-hour dynamic electrocardiogram, exercise electrocardiogram, thallium myocardial scintigraphy, and stress echocardiogram. A minority of the patients were seen only by the referring doctor, who provided us with a written report. The first 62 patients discharged from the hospital were chronologically asked to undergo a graft angiography 1 year after the operation. Written, informed consent was obtained from each patient before any investigation.

Vasoconstrictor Test
We compared the in vivo response of the RA, used as a graft, and of the pedicled LIMA to serotonin. This vasoactive substance was selectively infused into the LIMA and into the RA at increasing concentrations (10-6 and 10-5 mol/L) at a rate of 3 mL/min for 3 minutes. Finally, 2 mg of isosorbide dinitrate was injected into the RA. The angiograms obtained at baseline and after the consecutive infusions of serotonin and isosorbide dinitrate were analyzed using quantitative computerized angiography (Medis, Neuen, the Netherlands). The system had been validated and found to have a lower detection limit of 0.6 mm; thus vessels with an inferior value were considered to be 0.6 mm in diameter.

Magnetic Resonance Imaging
Examinations were performed with a GE Vectra 0.5 T machine. Axial scans were obtained from the aortic arch to a midventricular plane. Electrocardiogram-gated spin-echo was the technique of choice (matrix, 256 x 192; slice thickness, 5 mm). With the spin-echo sequence, the graft was considered patent if the normal intraluminal signal void was present in two or more anatomic levels; if the signal void was either seen only at one level or absent, the graft was considered to be occluded [12, 13].

Statistical Analysis
All results were expressed as means ± standard deviation, and differences were considered significant when the p value was less than 0.05. Risk factors, patency, and other categoric data were examined with contingency tables and {chi}2 or Fisher's exact test as appropriate. Independent predictors of graft patency were estimated by multiple logistic regression. For the comparison between two populations, the statistical analyses were made by the unpaired Student's t test for continuous variables and by {chi}2 for dichotomous variables.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Early Morbidity and Mortality
There were two operative deaths (1.82%): 1 patient died at the sixth postoperative hour, and the other died on the 30th day after the operation. When the first patient was in the intensive care unit, he suffered a large acute myocardial infarction in the territory revascularized by the left IMA and was returned urgently to the operative room where an irreversible spasm of the IMA and a thrombosed SVG were found. The left RA was found to be well functioning. The patient could not be resuscitated. The second death was due to irreversible degeneration of atrial fibrillation into ventricular fibrillation in the patient affected by Wolff-Parkinson-White syndrome, who was otherwise asymptomatic. This occurred because the known accessory pathway could not be ablated successfully at the moment of revascularization. No patients required specific inotropic support or counterpulsation, and none sustained major neurologic complications or RA harvesting-related events. In 2 patients (1.83%) a surgical revision was necessary because of IMA bleeding. A new Q wave was detected in 4 patients (3.6%): in 1 patient (who died at the sixth postoperative hour) it was in the IMA-dependent area, in 2 patients the acute myocardial infarction occurred in the GEA- and SVG-dependent areas, and finally in the last patient (0.9%) the acute myocardial infarction was in the area revascularized by the RA. The ventilatory support ranged from 0 hours (1 patient was extubated in the operating room) to 55 hours (mean, 13.12 ± 5.9 hours). One patient suffered a subcutaneous emphysema and another had a mediastinitis, which prolonged considerably his hospital stay. Finally 1 patient (0.9%) had a colon diverticulitis and a deep venous thrombosis of the leg. In 1 patient (0.9%), suffering from diffuse atherosclerotic disease, it was necessary to perform an axillo-femoral bypass 1 week after CABG due to the dramatic worsening of preexisting right leg claudication. All patients, apart from the 1 who died in the sixth hour, had a postoperative dynamic Doppler test to assess the vascularization of the forearm and the hand before discharge. The mean ventilatory support was 13.12 hours, whereas the mean hospitalization time was 9.8 ± 7.1 days (range, 5 to 67 days) for 107 patients (98.16%).

Follow-up
There were two late deaths (1.86%) 420 and 527 days after the operation caused by hepatic and intestinal tumors respectively, in otherwise "cardiac symptom-free" patients. At a mean interval of 532.42 ± 275.25 days (range, 47 to 1,024 days), 105 patients (98.13%) are still attending the follow-up program. The actuarial survival rate at 3 years is 85% for the whole population. Recurrent angina is present in 7 patients (6.66%). Among these, 2 patients (1.90%) required rehospitalization. The first patient underwent angiography 352 days after the operation: the composite graft was occluded. Subsequently he underwent two percutaneous transluminary coronary angioplasties on the distal left anterior descending artery with an apparently good result and relief of symptoms. Three months after this procedure the patient has been reoperated on for recurrent angina; today he is asymptomatic. The second patient underwent angiography at 240 days because of recurrent refractory angina: the GEA to the right posterior descending coronary artery showed an irreversible spasm, the LIMA to the LAD was occluded, and the RA to the first diagonal artery was patent. The patient was then reoperated on through a left lateral thoracotomy under hypothermia with a fibrillating heart. The total rate of reoperation is 1.9%. Residual ischemia, as documented by a reduced coronary reserve, was present in 4 patients: 3 patients complained of angina and 1 patient (0.95%) had silent ischemia. In 60 patients a dynamic Doppler test of the upper limb was repeated 1 year after operation and it was possible to detect adequate restoration of the preoperative blood flow to the hand in all of them. One patient (1.6%) had a paler hand in the absence of any symptoms. Three patients (2.85%) had subtle complaints of parahypesthesia of the forearm or of the first three fingers, whereas 2 patients (1.9%) complained of tension at the elbow-bend when overextending the forearm, probably resulting from the skin incision being too long.

Patency
To validate the surgical technique 18 patients (15.7%), chosen randomly from those operated on during the first year, were evaluated angiographically early after the operation (<6 months) at a mean interval of 24.3 days. There were 10 pretreated grafts and 7 composite grafts. Every other conduit was evaluated during the same procedure: 14 LIMA, 3 RIMA, 1 GEA, and 14 SVG were all patent. The overall RA conduit patency was 100%, but only 58.82% were judged to be angiographically satisfactory. Particularly in 2/7 group 2 patients (28.57%) the RA appeared to be diffusely narrowed, due to either a proximal or a DA stenosis, and in 1/11 group 1 patients (9.09%) the tract interposed between the latero-lateral and termino-lateral anastomoses of a sequential graft appeared to be narrowed by a DA stenosis. We proposed to repeat coronary angiography at 1 year to all 18 patients, but 2 group 1 patients and 1 group 2 patient refused. Of these patients, 1 in each group was then submitted to magnetic resonance imaging evaluation, which confirmed the previous normal aspect of the grafts. Finally, 14 patients (9 from group 1 and 5 from group 2) underwent a second study at a mean interval of 348.05 days from the first: the LIMAs, RIMAs, SVGs, and the GEA showed no change apart from 1 RIMA, which was occluded. The two composite grafts which already presented important lesions, were occluded. In contrast, the severely diseased pretreated grafts remained stable. Finally, 5 patients with marked irregularities or a small caliber showed an improvement in caliber and a considerably smoother inner lining.

One-Year Control
Fifty-six patients (52.33%) were consecutively restudied angiographically at a mean interval of 334.42 ± 83.25 days (range, 219 to 806 days). Among those patients who were asked to participate in the invasive follow-up, 3 patients (2.83%) were excluded: the first suffered from chronic renal failure; the second had sustained a monolateral amaurosis at the time of the preoperative study, and the third had experienced a significant deterioration of the preexisting lower limb arteriopathy. At the time of the study 1 patient (0.93%) had an important dye reaction that prevented the study being completed. Four patients (3.73%) refused to participate: 1 patient was then submitted to magnetic resonance imaging evaluation, as was the case for 2 patients among the 3 who already had an angiography before discharge. The results obtained with each surgical technique will be analyzed separately: group 1 and 2 populations were matched for demographic data, preoperative risk factors, and the mean follow-up interval. We applied a graft morphologic description (Table 3Go) to obtain, beyond the patency, a more detailed analysis of the graft, considering the concomitant IMA to be the reference.


View this table:
[in this window]
[in a new window]
 
Table 3. . Radial Artery Graft Morphology
 
GROUP 1.
Forty-nine patients (87.5%) had a pretreated RA graft: because 1 patient had the RA divided into 2 grafts and 5 patients received a sequential graft, a total of 50 grafts and 55 anastomoses were analyzed. A normal aspect was found in 76.74% of the patent grafts. In 2 patients (4.08%) a string-sign was noted; this was already present in the patient who had an angiography performed before discharge. Of the distal anastomoses, 88.89% were patent.

GROUP 2.
Seven patients (12.5%) had a composite RA graft: because they were all single grafts, 7 conduits and 7 anastomoses were analyzed. A normal aspect was found in 80% of the patent grafts. In none of these cases could a string sign be observed. Of the distal anastomoses, 62.5% were patent.

The conduit patency may shift from 87.75% to 88.23% and from 62.5% to 66.66% in groups 1 and 2, respectively, when taking into consideration the magnetic results.

Other Conduits
All data regarding IMAs, SVGs and GEAs are shown in Table 4Go. With regard to their aspect, it was considered normal in 86.95% of the IMAs, in 50% of the RIMAs, in 60% of the GEAs, and in 68.57% of the SVGs. The LIMA showed a significantly higher patency rate than the SVG (p = 0.03). The patency rate of the RA, considered as a whole, was not significantly different from that of the LIMA (p = 0.11) or of the SVG (p = 0.67). Comparable results were obtained when considering group 1 alone. On the contrary the patency rate of group 2 was comparable with that of the SVG (p = 0.36) but significantly less than the patency rate of the LIMA (p = 0.014). The patency rate of the RA was not significantly different when evaluated according to the territorial distribution of the DAs. The risk factors considered in Table 1Go and the postoperative symptoms or the calcium-channel blockers therapy were not found to be statistically significant predictors of short-term patency. According to the date of operation, there is an evident increase, although not statistically significant (p = 0.06), of the patency rate in those patients operated on after the first year of experience: from 70.4% (32 patients during the first year) to 96.2% (24 patients after the first year).


View this table:
[in this window]
[in a new window]
 
Table 4. . Graft Morphology
 
Vasoconstrictor Profile
Among the 56 patients who had control angiography at 1 year, 27 patients were submitted to a vasoreactivity test during the same procedure. The aim of this study was to compare the RA and IMA response to a vasoconstrictor stimulus, endogenous serotonin, as we reported previously [14]. Patients were divided into 2 groups depending upon whether or not calcium-blocker therapy had been discontinued at least 48 hours before the study. Selective infusion of increasing doses of serotonin (10-7 to 10-6 to 10-5 mol/L) elicited a marked constriction in the RA but not in the IMA (Table 5Go). Similar behavior was shown by both groups. In each case the constriction could be reversed by selective infusion of 2 mg isosorbide dinitrate. None of the patients complained of angina though in some deviation of ST segment was noted. It was apparent that 240 mg/day of oral diltiazem offers no protection against such an important stimulus.


View this table:
[in this window]
[in a new window]
 
Table 5. . Radial Artery Dose-Response Curve to Serotonin
 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Since the IMA has proved to be highly superior to any other conduit in terms of long-lasting patency [15], other arterial conduits have been proposed [1618]. Among these is the RA, which benefited from the widespread use of calcium antagonists. However, some resistance to the use of the RA persisted because early reports showed a relatively high incidence of spasm, covered too short a period, and were based on small numbers of patients. Therefore, 3 years ago we started a prospective study to assess the role of the RA in CABG. Initially we employed it in patients lacking other feasible conduits (eg, "redo" patients or those with varicose saphenous veins) and in those in whom harvesting of the IMAs could be particularly demanding (eg, after chest irradiation) or was contraindicated (eg, in insulin-dependent diabetes or after ipsilateral inferior epigastric artery harvesting). In overweight patients or in those with a gastrectomy, the GEA could not be harvested. As the number of redo operations for CABG increases it becomes useful to have one more conduit: in this case the arm to be used is the one spared by the blood-pressure monitoring line at the time of the first operation.

When the first series of angiographic controls showed satisfactory results, we broadened our indications: the RA was not proposed as a substitute for other conduits but in addition to those conduits. However, for ethical reasons, we regularly chose to revascularize (whenever possible) the most important coronary artery with the LIMA. Only in a minority of patients did the RA prove to be contraindicated. A small number of patients who were eligible for CABG with the RA were excluded as a positive dynamic Doppler test showed inadequate ulnar compensation or Doppler echocardiography revealed the presence of either atherosclerosis or anatomic lesions of the upper limb arteries, otherwise undetected by Allen test or routine physical examination. Indeed, in our series we did not encounter any major problem related to the RA harvesting.

From a technical point of view the RA has several advantages over other conduits: it can be dissected contemporaneously with other surgical procedures, its length allows grafting of all target vessels, its diameter matches with the diameter of most coronary arteries, and its resistant wall is easy to handle. Bilateral RAs have not been used because other arterial conduits have been available.

The longer-than-normal clamping time in our series can be explained by the policy we have adopted of performing the proximal anastomoses under aortic clamp to avoid multiple maneuvers on heavily calcified aortas and to reperfuse retrogradely with cardioplegia the "still ischemic" myocardial areas. In patients presenting with heavily calcified aortas we adopted three different techniques: fibrillating heart, proximal anastomosis to the innominate artery, and composite graft. After the first disappointing results we abandoned the composite technique; in fact, the RA is usually long enough to reach any coronary target even when anastomosed to the innominate artery. The observation that the RA reacts more than the LIMA in response to serotonin regardless of calcium-channel blocker therapy encouraged us to give more attention to the RA harvesting procedure. Those RA grafts affected by some degree of disease appear to be more reactive, although this is not statistically significant, than normal-looking grafts. This might explain the hypothesis of a protective role of the endothelial lining even 1 year after operation. It is important to underline that in those patients who presented spontaneously with a string sign at the angiographic control before discharge, a technical anastomotic defect was constantly noted. Furthermore, few grafts presenting with an abnormal aspect at the first angiography showed a normal aspect at the following. For this reason the clinical relevance of the morphologic and the histological alterations, as of the higher provoked reactivity of the RA, needs to be clarified [19]. Finally, the encouraging patency rate shown by the pretreated group (88.88%), higher than the reported patency for other free grafts [20] and considerably increased (96.2%) after the learning phase, may allow us to identify the RA as a satisfactory complementary graft to achieve complete arterial revascularization together with the LIMA and the GEA.

In conclusion, in our opinion it is essential to perform a complete physical and instrumental vascular examination of the upper limb prior to patient selection, and great care should be paid during RA harvesting. The radial artery is an easily manageable conduit, and spasm can be overcome by respecting the following: "no-touch" harvesting technique, meticulous opening of the pedicle's fascia, warm hematic cardioplegia in normothermia, continuous calcium-channel blocker therapy, and coronary target caliber greater than 1.5 mm with a good "run-off." However, a better understanding of its behavior and a longer follow-up are required to further broaden our indications.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
We express our gratitude to Alain F. Carpentier MD, PhD, and Christophe Acar, MD.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Presented at the Thirty-second Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 29–31, 1996.

Address reprint requests to Dr Manasse, Via Achille Loria 23, 00191 Roma, Italy.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Carpentier A, Guermonprez JL, Deloche A, Frechette C, Dubost C. The aorta-to-coronary radial artery bypass graft: a technique avoiding pathological changes in grafts. Ann Thorac Surg 1973;16:111–21.[Medline]
  2. Acar C, Jebara VA, Portoghese M, et al. Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg 1992;54:652–60.[Abstract]
  3. Fremes SE, Christakis GT, Del Rizzo DF, Musiani A, Mallidi H, Goldman BS. The technique of radial artery bypass grafting and early clinical results. J Cardiac Surg 1995;10:537–44.[Medline]
  4. Calafiore AM, Di Giammarco G, Teodori G, et al. Radial artery and inferior epigastric artery in composite grafts: improved midterm angiographic results. Ann Thorac Surg 1995;60:517–24.[Abstract/Free Full Text]
  5. Reyes AT, Frame R, Brodman RF. Technique for harvesting the radial artery as a coronary artery bypass graft. Ann Thorac Surg 1995;59:118–26.[Abstract/Free Full Text]
  6. Chardigny C, Jebara VA, Acar C, et al. Vasoreactivity of the radial artery. Circulation 1993;88:115–27.
  7. Lipper H, Pabst RA. Arteries of the forearm. In: Bergman JF, ed. Arterial variations in man: classifications and frequency. Munich: Springer Verlag, 1985:71–7.
  8. Pola P, Serricchio M, Flore R, Favuzzi A, Manasse E, Possati GF. CW Doppler evaluation of the forearm blood supply in patients submitted to myocardial revascularization with the radial artery (RA). In: Possati GF, Suma H, Alessandrini F, eds. Proceedings of the international workshop on arterial conduits for myocardial revascularization. Perugia: Galeno, 1994:275–82.
  9. Calafiore AM, Di Giammarco G, Luciani N, Maddestra N, Di Nardo E, Angelini R. Composite arterial conduits for a wider arterial myocardial revascularization. Ann Thorac Surg 1994;58:185–90.[Abstract]
  10. Van Son JAM, Tavilla G, Noyez L. Detrimental sequelae on the wall of the internal mammary artery caused by hydrostatic dilatation with diluted papaverine solution. J Thorac Cardiovasc Surg 1992;104:972–6.[Abstract]
  11. Fonger JD. Arterial conduit mechanical dilatation without shear force preserves endothelial function. Presented at the international workshop on arterial conduits for myocardial revascularization, Rome, Italy, Nov 16–18, 1994.
  12. Aurigemma GP, Reichek N, Axel L, Schielber M, Harris C, Kressel HY. Noninvasive determination of coronary artery bypass graft patency by cine magnetic resonance imaging. Circulation 1989;80:1595–602.[Abstract/Free Full Text]
  13. Jenkins JPR, Love HG, Foster GJ, Isherwood I, Rowlands DJ. Detection of coronary artery bypass graft patency as assessed by magnetic resonance imaging. Br J Radiol 1988;61:2–4.[Abstract/Free Full Text]
  14. Manasse E, Sperti G, Crea F, et al. Increased responsiveness to serotonin of radial artery grafts compared to internal mammary artery. In: Possati GF, Suma H, Alessandrini F, eds. Proceedings of the international workshop on arterial conduits for myocardial revascularization. Perugia: Galeno, 1994:63–72.
  15. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1–6.[Abstract]
  16. Barner HB, Naunheim KS, Fiore AC, Fischer VW, Harris HH. Use of the inferior epigastric artery as a free graft for myocardial revascularization. Ann Thorac Surg 1991;52:429–37.[Abstract]
  17. Suma H, Wanibuchi Y, Terada Y, Fukuda S, Takayama T, Furuta S. The right gastroepiploic artery graft. Clinical and angiographic midterm results in 200 patients. J Thorac Cardiovasc Surg 1993;105:615–23.[Abstract]
  18. Dietl CA, Madigan NP, Menapace FJ, et al. Results of coronary artery bypass grafting using multiple arterial conduits. J Cardiovasc Surg 1993;34:513–6.[Medline]
  19. Guo-Wei H, Cheng-Qin Y. Comparison among arterial grafts and coronary artery. J Thorac Cardiovasc Surg 1995;109:707–14.[Abstract/Free Full Text]
  20. Cremer J, Liesmann T, Wimmer-Greinecker G, Abraham C, Mugge A, Haverich A. In vivo comparison of free coronary grafts using the inferior epigastric (IEA), the gastroepiploic (GEA), and the internal thoracic artery (ITA). Eur J Cardiothorac Surg 1994;8:240–6.[Abstract]

Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 1082-1083. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Ding, W. Feng, H. Li, L. Wang, D. Li, Z. Cheng, J. Guo, and D. Hu
A comparative study on in vitro and in vivo effects of topical vasodilators in human internal mammary, radial artery and great saphenous vein
Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 536 - 541.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Collins, C. M. Webb, C. F. Chong, N. E. Moat, and for the Radial Artery Versus Saphenous Vein Patenc
Radial Artery Versus Saphenous Vein Patency Randomized Trial: Five-Year Angiographic Follow-Up
Circulation, June 3, 2008; 117(22): 2859 - 2864.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Di Lazzaro, T. Ragni, G. Di Manici, G. Bardelli, U. Da Col, F. Grasselli, A. Antoniella, W. Papa, F. Crusco, and A. Giovagnoni
Noninvasive midterm follow-up of radial artery bypass grafts with 16-slice computed tomography.
Ann. Thorac. Surg., July 1, 2006; 82(1): 44 - 50.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Gaudino, F. Glieca, N. Luciani, G. Losasso, P. Tondi, M. Serricchio, P. Pola, and G. Possati
Ten-year Echo-Doppler evaluation of forearm circulation following radial artery removal for coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 71 - 73.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Miwa, N. Desai, T. Koyama, E. Chan, E. A. Cohen, S. E. Fremes, and Radial Artery Patency Study Investigators
Radial Artery Angiographic String Sign: Clinical Consequences and the Role of Pharmacologic Therapy
Ann. Thorac. Surg., January 1, 2006; 81(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gaudino, F. Prati, E. Caradonna, C. Trani, F. Burzotta, G. Schiavoni, F. Glieca, and G. Possati
Implantation in Coronary Circulation Induces Morphofunctional Transformation of Radial Grafts From Muscular to Elastomuscular
Circulation, August 30, 2005; 112(9_suppl): I-208 - I-211.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. P. Georghiou, B. A. Vidne, and J. Dunning
Does the radial artery provide better long-term patency than the saphenous vein?
Interactive CardioVascular and Thoracic Surgery, August 1, 2005; 4(4): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Gaudino, M. Serricchio, P. Tondi, L. Gerardino, A. D. Giorgio, P. Pola, and G. Possati
Chronic compensatory increase in ulnar flow and accelerated atherosclerosis after radial artery removal for coronary artery bypass
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 9 - 12.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Gaudino, G. Nasso, C. Canosa, F. Glieca, A. Salica, F. Alessandrini, and G. Possati
Midterm Angiographic Patency and Vasoreactive Profile of Proximal Versus Distal Radial Artery Grafts
Ann. Thorac. Surg., June 1, 2005; 79(6): 1987 - 1989.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. R. Sajja, G. Mannam, N. R. Pantula, and S. Sompalli
Role of Radial Artery Graft in Coronary Artery Bypass Grafting
Ann. Thorac. Surg., June 1, 2005; 79(6): 2180 - 2188.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Gaudino, N. Luciani, G. Nasso, A. Salica, C. Canosa, and G. Possati
Is postoperative calcium channel blocker therapy needed in patients with radial artery grafts?
J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 532 - 535.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H.-S. Lee, Y. J. Heo, and B.-C. Chang
Long-term digital blood flow after radial artery harvesting for coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 99 - 103.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. F. Chong, P. J. L. Ong, N. Moat, and P. Collins
Effects of hydrostatic distention on in vitro vasoreactivity of radial artery conduits
J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verma, P. E. Szmitko, R. D. Weisel, D. Bonneau, D. Latter, L. Errett, Y. LeClerc, and S. E. Fremes
Should Radial Arteries Be Used Routinely for Coronary Artery Bypass Grafting?
Circulation, August 3, 2004; 110(5): e40 - e46.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H.-S. Lee, B.-C. Chang, and Y. J. Heo
Digital blood flow after radial artery harvest for coronary artery bypass grafting
Ann. Thorac. Surg., June 1, 2004; 77(6): 2071 - 2074.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Katai, I. Tsuneyoshi, J. Hamasaki, M. Onomoto, S. Suehiro, R. Sakata, and Y. Kanmura
The Variable Effects of Dopamine Among Human Isolated Arteries Commonly Used for Coronary Bypass Grafts
Anesth. Analg., April 1, 2004; 98(4): 915 - 920.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Gaudino, F. Alessandrini, C. Pragliola, C. Cellini, F. Glieca, N. Luciani, F. Girola, and G. Possati
Effect of target artery location and severity of stenosis on mid-term patency of aorta-anastomosed vs. internal thoracic artery-anastomosed radial artery grafts
Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 424 - 428.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. S. Corvera, C. D. Morris, J. M. Budde, D. A. Velez, J. D. Puskas, O. M. Lattouf, W. A. Cooper, R. A. Guyton, and J. Vinten-Johansen
Pretreatment with phenoxybenzamine attenuates the radial artery's vasoconstrictor response to {alpha}-adrenergic stimuli
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1549 - 1554.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Possati, M. Gaudino, F. Prati, F. Alessandrini, C. Trani, F. Glieca, M. A. Mazzari, N. Luciani, and G. Schiavoni
Long-Term Results of the Radial Artery Used for Myocardial Revascularization
Circulation, September 16, 2003; 108(11): 1350 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Gaudino, A. Toesca, N. Maggiano, C. Pragliola, and G. Possati
Localization of nitric oxide synthase type III in the internal thoracic and radial arteries and the great saphenous vein: A comparative immunohistochemical study
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1510 - 1515.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Beghi, F. Nicolini, A. M. Budillon, B. Borrello, L. Ballore, C. Reverberi, and T. Gherli
Midterm Clinical Results in Myocardial Revascularization Using the Radial Artery
Chest, December 1, 2002; 122(6): 2075 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Locker, R. Mohr, Y. Paz, O. Lev-Ran, I. Herz, G. Uretzky, and I. Shapira
Pretreatment with {alpha}-adrenergic blockers for prevention of radial artery spasm
Ann. Thorac. Surg., October 1, 2002; 74(4): S1368 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. S. Reddy, S. M. Parikh, D. C. Drinkwater Jr, A. Lo, T. P. Rauth, R. M. Moleski, and P. A. Chang
Morbidity after procurement of radial arteries in diabetic patients and the elderly undergoing coronary revascularization
Ann. Thorac. Surg., March 1, 2002; 73(3): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. M. Calafiore, M. D. Mauro, S. D'Alessandro, G. Teodori, G. Vitolla, M. Contini, A. L. Iaco, and G. Spira
Revascularization of the lateral wall: Long-term angiographic and clinical results of radial artery versus right internal thoracic artery grafting
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. E. Harrison, A. J. Mellor, J. Clark, and D. R. J. Singer
Vasodilator pre-treatment of human radial arteries; comparison of effects of phenoxybenzamine vs papaverine on norepinephrine-induced contraction in vitro
Eur. Heart J., December 1, 2001; 22(23): 2209 - 2216.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. V. Moran, R. Baeza, E. Guarda, R. Zalaquett, M. J. Irarrazaval, E. Marchant, and C. Deck
Predictors of radial artery patency for coronary bypass operations
Ann. Thorac. Surg., November 1, 2001; 72(5): 1552 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Prifti, M. Bonacchi, G. Frati, P. Proietti, G. Giunti, and M. Leacche
{lambda}graft with the radial artery or free left internal mammary artery anastomosed to the right internal mammary artery: flow dynamics
Ann. Thorac. Surg., October 1, 2001; 72(4): 1275 - 1281.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gaudino, F. Glieca, N. Luciani, F. Alessandrini, and G. Possati
Clinical and Angiographic Effects of Chronic Calcium Channel Blocker Therapy Continued Beyond First Postoperative Year in Patients With Radial Artery Grafts: Results of a Prospective Randomized Investigation
Circulation, September 18, 2001; 104 (2009): I-64 - I-67.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. L. Iaco, G. Teodori, G. Di Giammarco, M. Di Mauro, L. Storto, V. Mazzei, G. Vitolla, B. Mostafa, and A. M. Calafiore
Radial artery for myocardial revascularization: long-term clinical and angiographic results
Ann. Thorac. Surg., August 1, 2001; 72(2): 464 - 468.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. C. Anyanwu, I. Saeed, M. Bustami, C. Ilsley, M. H. Yacoub, and M. Amrani
Does routine use of the radial artery increase complexity or morbidity of coronary bypass surgery?
Ann. Thorac. Surg., February 1, 2001; 71(2): 555 - 559.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Cohen, M. G. Tamariz, J. Y. Sever, N. Liaghati, V. Guru, G. T. Christakis, G. Bhatnagar, C. Cutrara, L. Abouzahr, B. S. Goldman, et al.
The radial artery versus the saphenous vein graft in contemporary CABG: a case-matched study
Ann. Thorac. Surg., January 1, 2001; 71(1): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. E. Weinschelbaum, A. Macchia, V. M. Caramutti, H. A. Machain, H. A. Raffaelli, M. R. Favaloro, R. R. Favaloro, E. A. Dulbecco, J. A. Abud, M. D. Laurentiis, et al.
Myocardial revascularization with radial and mammary arteries: initial and mid-term results
Ann. Thorac. Surg., October 1, 2000; 70(4): 1378 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. M. Shapira, J. D. Alkon, D. S.F. Macron, J. F. Keaney Jr, J. A. Vita, G. S. Aldea, and R. J. Shemin
Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm
Ann. Thorac. Surg., September 1, 2000; 70(3): 883 - 888.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Gaudino, F. Glieca, C. Trani, A. Lupi, M. A. Mazzari, G. Schiavoni, and G. Possati
Midterm endothelial function and remodeling of radial artery grafts anastomosed to the aorta
J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 298 - 301.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Parolari, P. Rubini, F. Alamanni, A. Cannata, W. Xin, T. Gherli, G. Polvani, T. Toscano, M. Zanobini, and P. Biglioli
The radial artery: which place in coronary operation?
Ann. Thorac. Surg., April 1, 2000; 69(4): 1288 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. R. Sadaba, K. Mathew, C. M. Munsch, and D. J. Beech
Vasorelaxant properties of nicorandil on human radial artery
Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Sato, T. Isomura, H. Suma, T. Horii, and N. Kikuchi
Coronary artery bypass grafting with gastroepiploic artery composite graft
Ann. Thorac. Surg., January 1, 2000; 69(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Ruengsakulrach, R. Sinclair, M. Komeda, J. Raman, I. Gordon, and B. Buxton
Comparative Histopathology of Radial Artery Versus Internal Thoracic Artery and Risk Factors for Development of Intimal Hyperplasia and Atherosclerosis
Circulation, November 9, 1999; 100 (2009): II-139 - II-144.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. M. Shapira, A. Xu, J. A. Vita, G. S. Aldea, N. Shah, R. J. Shemin, and J. F. Keaney Jr
NITROGLYCERIN IS SUPERIOR TO DILTIAZEM AS A CORONARY BYPASS CONDUIT VASODILATOR
J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. G. Cable, J. A. Caccitolo, E. A. Pfeifer, R. C. Daly, J. A. Dearani, C. J. Mullany, T. O'Brien, T. A. Orszulak, and H. V. Schaff
Endothelial regulation of vascular contraction in radial and internal mammary arteries
Ann. Thorac. Surg., April 1, 1999; 67(4): 1083 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C.A Hamilton, R Williams, V Pathi, G Berg, K McArthur, A.R McPhaden, J.L Reid, and A.F Dominiczak
Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: comparison with internal thoracic artery
Cardiovasc Res, April 1, 1999; 42(1): 214 - 223.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Tashiro, K. Nakamura, A. Iwakuma, R. Zaitu, H. Iwahashi, A. Murai, and M. Kimura
Inverted T graft: novel technique using composite radial and internal thoracic arteries
Ann. Thorac. Surg., March 1, 1999; 67(3): 629 - 631.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. G. Cable, C. J. Mullany, and H. V. Schaff
The Allen test
Ann. Thorac. Surg., March 1, 1999; 67(3): 876 - 877.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. D. Loop
Coronary artery surgery: the end of the beginning
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 554 - 571.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Acar, A. Ramsheyi, J.-Y. Pagny, V. Jebara, P. Barrier, J.-N. Fabiani, A. Deloche, J.-L. Guermonprez, and A. Carpentier
THE RADIAL ARTERY FOR CORONARY ARTERY BYPASS GRAFTING: CLINICAL AND ANGIOGRAPHIC RESULTS AT FIVE YEARS
J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 981 - 989.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. H. Chester, A. J. Marchbank, J. A.A. Borland, M. H. Yacoub, and D. P. Taggart
Comparison of the morphologic and vascular reactivity of the proximal and distal radial artery
Ann. Thorac. Surg., December 1, 1998; 66(6): 1972 - 1976.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Possati, M. Gaudino, F. Alessandrini, N. Luciani, F. Glieca, C. Trani, C. Cellini, C. Canosa, and G. D. Sciascio
MIDTERM CLINICAL AND ANGIOGRAPHIC RESULTS OF RADIAL ARTERY GRAFTS USED FOR MYOCARDIAL REVASCULARIZATION
J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. A. Dumanian, K. Segalman, L. A. Mispireta, J. A. Walsh, M. F. Hendrickson, and E.F. S. Wilgis
Radial Artery Use in Bypass Grafting Does Not Change Digital Blood Flow or Hand Function
Ann. Thorac. Surg., May 1, 1998; 65(5): 1284 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. F. Buxton, A. T. Chan, A. S. Dixit, N. Eizenberg, R. D. Marshall, and J. S. Raman
Ulnar Artery as a Coronary Bypass Graft
Ann. Thorac. Surg., April 1, 1998; 65(4): 1020 - 1024.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Motwani and E. J. Topol
Aortocoronary Saphenous Vein Graft Disease : Pathogenesis, Predisposition, and Prevention
Circulation, March 10, 1998; 97(9): 916 - 931.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. O. Cheng
Radial Artery in Coronary Operations
Ann. Thorac. Surg., April 1, 1997; 63(4): 1209 - 1209.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eric Manasse
Hisayoshi Suma
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manasse, E.
Right arrow Articles by Possati, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manasse, E.
Right arrow Articles by Possati, G. F.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS